Publications by authors named "Emma Hernlund"

Claim this Profile
I
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.
Johan Dalén, Axel Svedbom, Emma Hernlund, Tor Olofsson, Christopher M Black

Adv Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
Axel Svedbom, Fredrik Borgstöm, Emma Hernlund, Vidmantas Alekna, Maria Luisa Bianchi

Qual Life Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.
Victoria Federico Paly, Murat Kurt, Lirong Zhang, Marcus O Butler, Olivier Michielin, Emma Hernlund

MDM Policy Pract· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic cost of AML in Sweden-A population-based study using multiple nation-wide registers.
Emma Hernlund, Josefine Redig, Björn Paulsson, Åsa Rangert Derolf, Martin Höglund

EJHaem· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
Axel Svedbom, Fredrik Borgström, Emma Hernlund, Oskar Ström, Vidmantas Alekna

Qual Life Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.
Xiaonan Zhang, Mårten Fryknäs, Emma Hernlund, Walid Fayad, Angelo De Milito

Nat Commun· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review.
Kun Kim, Emma Hernlund, Zoltán Hernadi, János Révész, Imre Pete

Int J Gynecol Cancer· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapy.
Emma Hernlund, Maria Hägg Olofsson, Walid Fayad, Mårten Fryknäs, Karolina Lesiak-Mieczkowska

Eur J Cancer· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Emma Hernlund, Elisabet Hjerpe, Elisabeth Avall-Lundqvist, Maria Shoshan

Mol Cancer Ther· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation.
Emma Hernlund, Ozgur Kutuk, Huveyda Basaga, Stig Linder, Theocharis Panaretakis

Free Radic Biol Med· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosis.
Maria Berndtsson, Emma Hernlund, Maria C Shoshan, Stig Linder

J Chem Biol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.
Victoria Hellberg, Inger Wallin, Sofi Eriksson, Emma Hernlund, Elin Jerremalm

J Natl Cancer Inst· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir.
Emma Hernlund, Linda Strandberg Ihrlund, Omar Khan, Yildiz Ozlem Ates, Stig Linder

Int J Cancer· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
3
3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
Linda Strandberg Ihrlund, Emma Hernlund, Omar Khan, Maria C Shoshan

Mol Oncol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two distinct steps of Bak regulation during apoptotic stress signaling: different roles of MEKK1 and JNK1.
Linda Strandberg Ihrlund, Emma Hernlund, Kristina Viktorsson, Theocharis Panaretakis, Gabor Barna

Exp Cell Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis